Spectranetics Corp. recently announced the availability of its LLD EZ Lead Locking Device (LLD) for the removal of nonfunctional or infected pacing and defibrillation leads. The LLD EZ is designed to enable physicians to secure the entire lead creating traction to enable the removal process.

Philips Healthcare has developed a hand-carried ultrasound with reportedly advanced imaging quality. The CX50 CompactXtreme was released in 2009. Primarily designed for echocardiography, the CX50 was designed with many of the same features of the iE33 echocardiography system, providing clinicians a portable ultrasound that can be used for diagnosis.

LUMEDX Corp. offers the CardioPACS 5.0, the latest version of its cardiology PACS software.

The multimodality, Web-enabled and vendor-neutral CardioPACS 5.0 offers new ways to manage images and data with a fully integrated suite of applications and modules.
With CardioPACS 5.0, physicians can view diagnostic-quality images in real time from any network-connected PC in any location the OR, cath lab, or in their offices, remote outreach or mobile clinics.

September 2, 2008 - Merit Medical Systems Inc., a manufacturer of disposable devices used primarily in cardiology and radiology procedures, today said five new products are scheduled to be introduced over the next few months.

September 2, 2008 - The safety debate about drug-eluting stents (DES) is still ongoing and in these times of uncertainty about DES safety, a new study has shown DES markedly improves long-term survival, compared to modern bare-metal stents (BMS) in patients with acute ST-segment elevation myocardial infarction (STEMI).

September 2, 2008 – The European Society of Cardiology (ESC) released new guidelines for how doctors should handle an acute pulmonary embolism (PE), during its 2008 Congress in Munich, Germany today.

September 1, 2008 - Depression and heart disease are the two leading disorders with the strongest contributions to the global burden of disease, and several large studies suggest the two are intertwined.

September 3, 2008 - Edwards Lifesciences Corp. today said it received FDA approval for the Carpentier-Edwards PERIMOUNT Magna mitral heart valve, which the company plans to immediately launch for sale in the U.S.

Designed for the treatment of mitral valve disease, one of the most common forms of heart valve disease in the world, the PERIMOUNT Magna mitral valve is a pericardial tissue-based bioprosthetic device that replaces a patient’s diseased mitral valve. Industry estimates indicate that there will be 35,000-40,000 surgical mitral valve replacements in the U.S. in 2008.

Edwards Lifesciences Corp. produces the Carpentier-Edwards

The PERIMOUNT Magna mitral valve was launched in Europe in September 2005. It incorporates features of the Carpentier-Edwards PERIMOUNT mitral valve, which has demonstrated 16 years of durability, including the treatment of the bovine pericardial tissue leaflets with the Carpentier-Edwards ThermaFix process.

September 2008

September 2, 2008 – Two recent studies demonstrate the economical value of cardiac imaging, showing MDCT to be cost-effective for men and cost-saving for women, and demonstrating how echo is cost-effective in determining patient eligibility for ICDs (implantable cardioverter-defibrillators).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now